Flow cytometry in immunoglobulin light chain amyloidosis: Short review

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F15%3A00081728" target="_blank" >RIV/00216224:14110/15:00081728 - isvavai.cz</a>
Alternative codes found
RIV/00843989:_____/15:E0105211 RIV/61988987:17110/15:A1601FXS RIV/00216224:14110/15:00108744
Result on the web
<a href="http://dx.doi.org/10.1016/j.leukres.2015.07.002" target="_blank" >http://dx.doi.org/10.1016/j.leukres.2015.07.002</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.leukres.2015.07.002" target="_blank" >10.1016/j.leukres.2015.07.002</a>

Result language
angličtina
Original language name
Flow cytometry in immunoglobulin light chain amyloidosis: Short review
Original language description
Flow cytometry (FCM) has found its application in clinical diagnosis and evaluation of monoclonal gammopathies (MG). Although, research has been mainly focused on multiple myeloma (MM), nowadays FCM becomes to be potential tool in the field of AL amyloidosis. Clonal plasma cells identification and specific phenotype profile detection is important for diagnosis, monitoring and prognosis of AL amyloidosis. Therefore, FCM could be a perspective method for study not only MM but also AL amyloidosis. This review provides an overview and possibilities of FCM application in AL amyloidosis. (C) 2015 Elsevier Ltd. All rights reserved.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)